Status:
COMPLETED
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
Lead Sponsor:
Indiana University
Conditions:
SARS-CoV-2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to validate the use of a rapid, at home, point-of-care (POC) SARS-CoV-2 IgG antibody test in high risk healthcare workers. Additionally, we would like to evaluate the inci...
Detailed Description
The success of Singapore, Taiwan and Hong Kong in limiting the impact of the sudden acute respiratory syndrome coronavirus-2 (SARS-CoV-2), also know as COVID-19, has been attributed to their preparedn...
Eligibility Criteria
Inclusion
- High risk healthcare workers, prioritizing those who are exposed to aerosol generating procedures (physicians and respiratory therapist) working in the emergency room or intensive care units at Indiana University Health or IU school of Medicine affiliated facilities. A second tier of prioritization, to be approached if testing capacity remains after the initial testing phase, will be nurses working these same areas
- Health care workers who are currently out sick or quarantined due to possible/known exposure to COVID-19 and whose physician confirms that a negative test would allow their return to work are also eligible for testing (Subjects in this group may begin study procedures and be registered once they reach the end of their quarantine period)
Exclusion
- 1\. Previously tested for COVID-19
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
571 Patients enrolled
Trial Details
Trial ID
NCT04334876
Start Date
April 1 2020
End Date
January 1 2021
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Health Hospital
Indianapolis, Indiana, United States, 46202